Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3593]

First of its kind research models immune responses in cellular immunotherapies

First of its kind research models immune responses in cellular immunotherapies

Specific CD8 T cell states may indicate response to immune checkpoint therapy for melanoma

Specific CD8 T cell states may indicate response to immune checkpoint therapy for melanoma

Two-cells-in-one combo therapy could bolster leukaemia treatment

Two-cells-in-one combo therapy could bolster leukaemia treatment

TIM-3 a promising new target for immunotherapy

TIM-3 a promising new target for immunotherapy

Anti-cancer virus fits tumour receptor like a 'key in a lock'

Anti-cancer virus fits tumour receptor like a 'key in a lock'

Electron microscopy images reveal how an anti-cancer virus interacts with tumour cells

Electron microscopy images reveal how an anti-cancer virus interacts with tumour cells

Aggressive treatment for some stage IV lung cancer patients can dramatically improve OS

Aggressive treatment for some stage IV lung cancer patients can dramatically improve OS

Scientists neutralise reactive nitrogen molecules to enhance cancer immunotherapy

Scientists neutralise reactive nitrogen molecules to enhance cancer immunotherapy

New drug candidates reverse drug resistance in multiple myeloma in preclinical models

New drug candidates reverse drug resistance in multiple myeloma in preclinical models

Suppression of DKK3 protein thwarts pancreatic tumour progression and prolongs survival

Suppression of DKK3 protein thwarts pancreatic tumour progression and prolongs survival

More from ecancer